• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Cannabigerol

CAS No. 25654-31-3

Cannabigerol ( —— )

产品货号. M24154 CAS No. 25654-31-3

Cannabigerol is a high affinity α±2-adrenergic receptor agonist, moderate affinity 5-HT1A receptor antagonist, and low affinity CB1 receptor antagonist ; also binds to the CB2 receptor; it can relieve interocular pressure, which may be of benefit in the treatment of glaucoma.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥1831 有现货
5MG ¥2681 有现货
10MG ¥4034 有现货
25MG ¥6893 有现货
50MG ¥9477 有现货
100MG ¥12798 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Cannabigerol
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Cannabigerol is a high affinity α±2-adrenergic receptor agonist, moderate affinity 5-HT1A receptor antagonist, and low affinity CB1 receptor antagonist ; also binds to the CB2 receptor; it can relieve interocular pressure, which may be of benefit in the treatment of glaucoma.
  • 产品描述
    Cannabigerol is a high affinity α±2-adrenergic receptor agonist, moderate affinity 5-HT1A receptor antagonist, and low affinity CB1 receptor antagonist ; also binds to the CB2 receptor; it can relieve interocular pressure, which may be of benefit in the treatment of glaucoma.
  • 同义词
    ——
  • 通路
    Endocrinology/Hormones
  • 靶点
    5-HT Receptor
  • 受体
    5-HT;NOS;ROS
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    25654-31-3
  • 分子量
    316.5
  • 分子式
    C21H32O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    CCCCCc1cc(O)c(C/C=C(\C)/CCC=C(C)C)c(O)c1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • Cyproheptadine hydro...

    Cyproheptadine hydrochloride sesquihydrate is an antihistamine and is an antagonist of serotonin and histamine2.

  • Mosapride Citrate

    Mosapride Citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.

  • Molindone hydrochlor...

    Molindone is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.